Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Tia Sternat, Kathryn Fotinos, Alexa Fine, Irvin Epstein & Martin A Katzman. (2018) Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults. Neuropsychiatric Disease and Treatment 14, pages 2379-2387.
Read now
Read now
Xiangying Yang, Xiaolu Chen, Yixiao Fu, Qinghua Luo, Lian Du, Haitang Qiu, Tian Qiu, Li Zhang & Huaqing Meng. (2018) Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials. Neuropsychiatric Disease and Treatment 14, pages 1297-1305.
Read now
Read now
Mehala Subramaniapillai, Nicole E. Carmona, Carola Rong & Roger S. McIntyre. (2017) Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders. Dialogues in Clinical Neuroscience 19:1, pages 27-36.
Read now
Read now
Giovanni Camardese, Beniamino Leone, Riccardo Serrani, Coco Walstra, Marco Di Nicola, Giacomo Della Marca, Pietro Bria & Luigi Janiri. (2015) Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients. Neuropsychiatric Disease and Treatment 11, pages 2331-2338.
Read now
Read now
Marcelo T. Berlim, Frederique Van den Eynde, Santiago Tovar-Perdomo, Eduardo Chachamovich, Abraham Zangen & Gustavo Turecki. (2014) Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression. The World Journal of Biological Psychiatry 15:7, pages 570-578.
Read now
Read now
Cindy L. Hovington, Alexander McGirr, Martin Lepage & Marcelo T. Berlim. (2013) Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analyses. Annals of Medicine 45:4, pages 308-321.
Read now
Read now
Susan L McElroy, Anna I Guerdjikova, Nicole Mori & Anne M O’Melia. (2012) Pharmacological management of binge eating disorder: current and emerging treatment options. Therapeutics and Clinical Risk Management 8, pages 219-241.
Read now
Read now
Khalid Saad Al-Harbi & Naseem Akhtar Qureshi. (2012) Neuromodulation therapies and treatment-resistant depression. Medical Devices: Evidence and Research 5, pages 53-65.
Read now
Read now
Regina M Carney & Richard C Shelton. (2011) Agomelatine for the treatment of major depressive disorder. Expert Opinion on Pharmacotherapy 12:15, pages 2411-2419.
Read now
Read now
Articles from other publishers (62)
Kimberlyn Maravet Baig-Ward, Manish Kumar Jha & Madhukar H. Trivedi. (2023) The Individual and Societal Burden of Treatment-Resistant Depression. Psychiatric Clinics of North America 46:2, pages 211-226.
Crossref
Crossref
Joshua Willms, Ben McCauley, Lindsay Kerr, Peyton Presto, Ankith Arun, Nazeen Shah, Kierra Irby, Megan Strawn & Jonathan Kopel. (2022) Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder. Frontiers in Psychiatry 13.
Crossref
Crossref
Yaron Ilan. (2022) Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases. Journal of Personalized Medicine 12:8, pages 1303.
Crossref
Crossref
Jifei Sun, Yue Ma, Limei Chen, Zhi Wang, Chunlei Guo, Yi Luo, Deqiang Gao, Xiaojiao Li, Ke Xu, Yang Hong, Xiaobing Hou, Jing Tian, Xue Yu, Hongxing Wang, Jiliang Fang & Xue Xiao. (2022) Altered Brain Function in Treatment-Resistant and Non-treatment-resistant Depression Patients: A Resting-State Functional Magnetic Resonance Imaging Study. Frontiers in Psychiatry 13.
Crossref
Crossref
Estela Saez, Leire Erkoreka, Teresa Moreno-Calle, Belen Berjano, Ana Gonzalez-Pinto, Nieves Basterreche & Aurora Arrue. (2022) Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature. World Journal of Psychiatry 12:7, pages 884-896.
Crossref
Crossref
Matthew Squires, Xiaohui Tao, Soman Elangovan, Raj Gururajan, Xujuan Zhou & Udyavara Rajendra Acharya. (2022) A novel genetic algorithm based system for the scheduling of medical treatments. Expert Systems with Applications 195, pages 116464.
Crossref
Crossref
Ellen Scotton, Bárbara Antqueviezc, Mailton França de Vasconcelos, Giovana Dalpiaz, Luiza Paul Géa, Jéferson Ferraz Goularte, Rafael Colombo & Adriane Ribeiro Rosa. (2022) Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers. Biochemical Pharmacology 198, pages 114963.
Crossref
Crossref
Dan Tuinstra, Chad Percifield, Kellen Stilwell, Aaron Plattner, Evonne Edwards, William Sanders & Michael Koval. (2022) Treatment of anxiety symptoms in patients receiving rTMS for treatment resistant depression. Psychiatry Research Communications 2:1, pages 100014.
Crossref
Crossref
Vali Musazadeh, Meysam Zarezadeh, Amir Hossein Faghfouri, Majid Keramati, Zohreh Ghoreishi & Alireza Farnam. (2022) Saffron, as an adjunct therapy, contributes to relieve depression symptoms: An umbrella meta-analysis. Pharmacological Research 175, pages 105963.
Crossref
Crossref
Laurent Michel, Sao Mai Le, Giang Hoang Thi, Philippe Trouiller, Huong Duong Thi, Oanh Khuat Thi Hai, Khue Pham Minh, Roselyne Vallo, Delphine Rapoud, Catherine Quillet, Thuy Linh Nguyen, Quang Duc Nguyen, Tuyet Thanh NhamThi, Jonathan Feelemyer, Vinh Vu Hai, Jean-Pierre Moles, Hong Quang Doan, Didier Laureillard, Don C. Des Jarlais & Nicolas Nagot. (2022) Assessment of a psychiatric intervention at community level for people who inject drugs in a low-middle income country: the DRIVE-Mind cohort study in Hai Phong, Viet Nam. The Lancet Regional Health - Western Pacific 18, pages 100337.
Crossref
Crossref
Samuel Zibman, Gaby S. Pell, Noam Barnea-Ygael, Yiftach Roth & Abraham Zangen. (2021) Application of transcranial magnetic stimulation for major depression: Coil design and neuroanatomical variability considerations. European Neuropsychopharmacology 45, pages 73-88.
Crossref
Crossref
Yuan Hu, Chao Chen, Yichen Wang, Wenshan Yang, Yuanbo Wang, Weiyu Zhu, Can Yan & Ping Liu. (2021) The effects of KaiXinSan on depression and its association with lipid profiles: A randomized, double-blinded, placebo-controlled trial. Phytomedicine 83, pages 153467.
Crossref
Crossref
Shawn M. Arent, Alan J. Walker & Michelle A. Arent. 2020. Handbook of Sport Psychology. Handbook of Sport Psychology
872
890
.
Jonathan Repple, Susanne Meinert, Irene Bollettini, Dominik Grotegerd, Ronny Redlich, Dario Zaremba, Christian Bürger, Katharina Förster, Katharina Dohm, Felix Stahl, Nils Opel, Tim Hahn, Verena Enneking, Elisabeth J. Leehr, Joscha Böhnlein, Ramona Leenings, Claas Kaehler, Daniel Emden, Nils R. Winter, Walter Heindel, Harald Kugel, Jochen Bauer, Volker Arolt, Francesco Benedetti & Udo Dannlowski. (2019) Influence of electroconvulsive therapy on white matter structure in a diffusion tensor imaging study. Psychological Medicine 50:5, pages 849-856.
Crossref
Crossref
Bradley N. Gaynes, Linda Lux, Gerald Gartlehner, Gary Asher, Valerie Forman‐Hoffman, Josh Green, Erin Boland, Rachel P. Weber, Charli Randolph, Carla Bann, Emmanuel Coker‐Schwimmer, Meera Viswanathan & Kathleen N. Lohr. (2019) Defining treatment‐resistant depression. Depression and Anxiety 37:2, pages 134-145.
Crossref
Crossref
Joseph Mehltretter, Colleen Rollins, David Benrimoh, Robert Fratila, Kelly Perlman, Sonia Israel, Marc Miresco, Marina Wakid & Gustavo Turecki. (2020) Analysis of Features Selected by a Deep Learning Model for Differential Treatment Selection in Depression. Frontiers in Artificial Intelligence 2.
Crossref
Crossref
Yafang Zhang, Elizabeth J. Crofton, Tileena E.S. Smith, Shyny Koshy, Dingge Li & Thomas A. Green. (2019) Manipulation of retinoic acid signaling in the nucleus accumbens shell alters rat emotional behavior. Behavioural Brain Research 376, pages 112177.
Crossref
Crossref
Narumi Hashikawa-Hobara, Ami Otsuka, Risa Ishikawa & Naoya Hashikawa. (2019) Roman chamomile inhalation combined with clomipramine treatment improves treatment-resistant depression-like behavior in mice. Biomedicine & Pharmacotherapy 118, pages 109263.
Crossref
Crossref
Dominic Pilon, John J. Sheehan, Holly Szukis, Laura Morrison, Maryia Zhdanava, Patrick Lefebvre & Kruti Joshi. (2019) Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?. Journal of Affective Disorders 255, pages 50-59.
Crossref
Crossref
Martina Balestri, Stefano Porcelli, Daniel Souery, Siegfried Kasper, Dimitris Dikeos, Panagiotis Ferentinos, George N. Papadimitriou, Dan Rujescu, Giovanni Martinotti, Marco Di Nicola, Luigi Janiri, Elisabetta Caletti, Gian Mario Mandolini, Alessandro Pigoni, Riccardo Augusto Paoli, Matteo Lazzaretti, Paolo Brambilla, Michela Sala, Vera Abbiati, Marcella Bellani, Cinzia Perlini, Maria Gloria Rossetti, Sara Piccin, Carolina Bonivento, Dora Fabbro, Giuseppe Damante, Clarissa Ferrari, Roberta Rossi, Laura Pedrini, Francesco Benedetti, Stuart Montgomery, Joseph Zohar, Julien Mendlewicz & Alessandro Serretti. (2019) Temperament and character influence on depression treatment outcome. Journal of Affective Disorders 252, pages 464-474.
Crossref
Crossref
D.R. Waring. (2019) Wishing you won’t be here: Medical assistance in dying for psychiatric patients. Ethics, Medicine and Public Health 8, pages 1-10.
Crossref
Crossref
Kelly Perlman, David Benrimoh, Sonia Israel, Colleen Rollins, Eleanor Brown, Jingla-Fri Tunteng, Raymond You, Eunice You, Myriam Tanguay-Sela, Emily Snook, Marc Miresco & Marcelo T. Berlim. (2019) A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder. Journal of Affective Disorders 243, pages 503-515.
Crossref
Crossref
Swati Sahoo & Brijesh S.. (2019) Pharmacogenomic assessment of herbal drugs in affective disorders. Biomedicine & Pharmacotherapy 109, pages 1148-1162.
Crossref
Crossref
Lison Huet, Ines Delgado, Bruno Aouizerate, Nathalie Castanon & Lucile Capuron. 2019. Neurobiology of Depression. Neurobiology of Depression
169
183
.
Tonghui Su, Yi Lu, Yang Geng, Wei Lu & Yelin Chen. (2019) How could N-Methyl-D-Aspartate Receptor Antagonists Lead to Excitation Instead of Inhibition?. Brain Science Advances 4:2, pages 73-98.
Crossref
Crossref
Marco Calabrò, Chiara Fabbri, Concetta Crisafulli, Diego Albani, Gianluigi Forloni, Siegfried Kasper, Antonina Sidoti, Elvira Velardi, Joseph Zohar, Alzbeta Juven-Wetzler, Daniel Souery, Stuart Montgomery, Julien Mendlewicz & Alessandro Serretti. (2018) The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants. Human Psychopharmacology: Clinical and Experimental 33:6, pages e2682.
Crossref
Crossref
Reza Shalbaf, Colleen Brenner, Christopher Pang, Daniel M. Blumberger, Jonathan Downar, Zafiris J. Daskalakis, Joseph Tham, Raymond W. Lam, Faranak Farzan & Fidel Vila-Rodriguez. (2018) Non-linear Entropy Analysis in EEG to Predict Treatment Response to Repetitive Transcranial Magnetic Stimulation in Depression. Frontiers in Pharmacology 9.
Crossref
Crossref
Hee-Ju Kang, Ju-Wan Kim, Seon-Young Kim, Sung-Wan Kim, Hee-Young Shin, Myung-Geun Shin & Jae-Min Kim. (2018) The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response Study: Design and Methodology. Psychiatry Investigation 15:5, pages 538-545.
Crossref
Crossref
Daniel G. Amen, Derek V. Taylor, Somayeh Meysami & Cyrus A. Raji. (2018) Deficits in Regional Cerebral Blood Flow on Brain SPECT Predict Treatment Resistant Depression. Journal of Alzheimer's Disease 63:2, pages 529-538.
Crossref
Crossref
Alexandre Dardenne, Chris Baeken, Cleo L. Crunelle, Chris Bervoets, Frieda Matthys & Sarah C. Herremans. (2018) Accelerated HF-rTMS in the elderly depressed: A feasibility study. Brain Stimulation 11:1, pages 247-248.
Crossref
Crossref
David Benrimoh, Robert Fratila, Sonia Israel, Kelly Perlman, Nykan Mirchi, Sneha Desai, Ariel Rosenfeld, Sabrina Knappe, Jason Behrmann, Colleen Rollins, Raymond Penh You & The Aifred Health Team. 2018. The NIPS '17 Competition: Building Intelligent Systems. The NIPS '17 Competition: Building Intelligent Systems
251
287
.
Vladimír Tuka, Martina Daňková, Karel Riegel & Martin Matoulek. (2017) Physical activity - the Holy Grail of modern medicine?. Vnitřní lékařství 63:10, pages 729-736.
Crossref
Crossref
Masaki NishidaSenichiro KikuchiKoichi NisijimaShiro Suda. (2017) Actigraphy in Patients With Major Depressive Disorder Undergoing Repetitive Transcranial Magnetic Stimulation. The Journal of ECT 33:1, pages 36-42.
Crossref
Crossref
J.C. Morales-Medina, T. Iannitti, A. Freeman & H.K. Caldwell. (2017) The olfactory bulbectomized rat as a model of depression: The hippocampal pathway. Behavioural Brain Research 317, pages 562-575.
Crossref
Crossref
Nolan R. Williams, E. Baron Short, Thomas Hopkins, Brandon S. Bentzley, Greg L. Sahlem, Jaspreet Pannu, Matt Schmidt, Jeff J. Borckardt, Jeffrey E. Korte, Mark S. George, Istvan Takacs & Ziad Nahas. (2016) Five-Year Follow-Up of Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression. Brain Stimulation 9:6, pages 897-904.
Crossref
Crossref
Ali Sahraian, Sina Jelodar, Zahra Javid, Arash Mowla & Laaya Ahmadzadeh. (2016) Study the effects of saffron on depression and lipid profiles: A double blind comparative study. Asian Journal of Psychiatry 22, pages 174-176.
Crossref
Crossref
Vera De Carlo, Raffaella Calati & Alessandro Serretti. (2016) Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review. Psychiatry Research 240, pages 421-430.
Crossref
Crossref
Nolan R Williams & Alan F Schatzberg. (2016) NMDA antagonist treatment of depression. Current Opinion in Neurobiology 36, pages 112-117.
Crossref
Crossref
Martina Balestri, Raffaella Calati, Daniel Souery, Alexander Kautzky, Siegfried Kasper, Stuart Montgomery, Joseph Zohar, Julien Mendlewicz & Alessandro Serretti. (2016) Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study. Journal of Affective Disorders 189, pages 224-232.
Crossref
Crossref
Larry Culpepper, Philip R. Muskin & Stephen M. Stahl. (2015) Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability. The American Journal of Medicine 128:9, pages S1-S15.
Crossref
Crossref
Aaron J Fisher & Hannah G Bosley. (2015) Personalized assessment and treatment of depression. Current Opinion in Psychology 4, pages 67-74.
Crossref
Crossref
. 2014. Biomarkers of Brain Injury and Neurological Disorders. Biomarkers of Brain Injury and Neurological Disorders
433
459
.
Yoo-Hyun Um, Hyu-Jung Huh, Sun-Young Kim & Jeong-Ho Chae. (2014) Possible cultural effects on the increments of somatic symptoms in subjectively resilient depressed patients. Asia-Pacific Psychiatry 6:3, pages 259-266.
Crossref
Crossref
David Abookasis, Ariel Shochat, Elimelech Nesher & Albert Pinhasov. (2014) Exploring diazepam’s effect on hemodynamic responses of mouse brain tissue by optical spectroscopic imaging. Biomedical Optics Express 5:7, pages 2184.
Crossref
Crossref
M. T. Berlim, F. van den Eynde, S. Tovar-Perdomo & Z. J. Daskalakis. (2013) Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychological Medicine 44:2, pages 225-239.
Crossref
Crossref
Melissa L. Barron, Eryn L. Werry, Iain S. McGregor & Michael Kassiou. 2014. Pathologies of Calcium Channels. Pathologies of Calcium Channels
635
661
.
Thomas L. Schwartz. (2013) A neuroscientific update on monoamine oxidase and its inhibitors. CNS Spectrums 18:s1, pages 22-33.
Crossref
Crossref
Mubarek Abera, Kenfe Tesfay, Tariku Dejene, Mirkuzie Kerie & Sudhakar Morankar. (2013) Efficacy of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in the treatment of medication resistant major depressive disorder: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports 11:11, pages 1-7.
Crossref
Crossref
Joseph Ciccolo & William KraemerShawn Arent & Brandon Alderman. 2013. Resistance Training for the Prevention and Treatment of Chronic Disease. Resistance Training for the Prevention and Treatment of Chronic Disease
161
176
.
Donald F. Smith. (2013) Benefits of flavanol-rich cocoa-derived products for mental well-being: A review. Journal of Functional Foods 5:1, pages 10-15.
Crossref
Crossref
Nils Gebhardt, Karl-Jürgen Bär, Michael K. Boettger, Gisela Grecksch, Gerburg Keilhoff, Rupert Reichart & Axel Becker. (2013) Vagus nerve stimulation ameliorated deficits in one-way active avoidance learning and stimulated hippocampal neurogenesis in bulbectomized rats. Brain Stimulation 6:1, pages 78-83.
Crossref
Crossref
Masatake Kurita, Satoshi Nishino, Maiko Kato, Yukio Numata & Tadahiro Sato. (2012) Plasma Brain-Derived Neurotrophic Factor Levels Predict the Clinical Outcome of Depression Treatment in a Naturalistic Study. PLoS ONE 7:6, pages e39212.
Crossref
Crossref
Sam Restifo. (2012) Walking on thin ice: the use of triple antidepressant combinations in refractory melancholic depression. Australasian Psychiatry 20:2, pages 134-137.
Crossref
Crossref
Emily Jenkins & Elliot M. Goldner. (2012) Approaches to Understanding and Addressing Treatment-Resistant Depression: A Scoping Review. Depression Research and Treatment 2012, pages 1-7.
Crossref
Crossref
Cecilio Lopez-Munoz & Francisco AlamoJulio Morales-Medina & Rémi Quirion. 2011. Neurobiology of Depression. Neurobiology of Depression
325
340
.
Arash Mowla & Ehsan Kardeh. (2011) Topiramate augmentation in patients with resistant major depressive disorder: A double-blind placebo-controlled clinical trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:4, pages 970-973.
Crossref
Crossref
Marcelo T. Berlim, Alexander McGirr, Marie-Martine Beaulieu & Gustavo Turecki. (2011) High frequency repetitive transcranial magnetic stimulation as an augmenting strategy in severe treatment-resistant major depression: A prospective 4-week naturalistic trial. Journal of Affective Disorders 130:1-2, pages 312-317.
Crossref
Crossref
Peter J. Carek, Sarah E. Laibstain & Stephen M. Carek. (2011) Exercise for the Treatment of Depression and Anxiety. The International Journal of Psychiatry in Medicine 41:1, pages 15-28.
Crossref
Crossref
Julio César Morales-Medina, Yvan Dumont & Rémi Quirion. (2010) A possible role of neuropeptide Y in depression and stress. Brain Research 1314, pages 194-205.
Crossref
Crossref
Jerome Sarris, David J. Kavanagh & Gerard Byrne. (2010) Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. Journal of Psychiatric Research 44:1, pages 32-41.
Crossref
Crossref
Thorsten Mikoteit & Martin Hatzinger. (2009) Chronische Depression. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 57:4, pages 245-251.
Crossref
Crossref
Gin S Malhi. (2008) Upping the ante on antidepressants. Bipolar Disorders 10:8, pages 975-978.
Crossref
Crossref